Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Liana Baker"'
Autor:
Brian K. Fiske, Tanya Simuni, Melissa Kostrzebski, Ted M. Dawson, Kalpana Merchant, Chelsea Caspell-Garcia, Richard K. Wyse, Patrik Brundin, David Erick Lafontant, Gary Rafaloff, Charles S. Venuto, Liana Baker, Christopher S. Coffey, Helen Matthews, Jaime Adams, Elizabeth A. Klingner, David B. Weiner, Tina Ward, Michael A. Schwarzschild, David Simon
BackgroundNilotinib, a tyrosine kinase Abelson inhibitor, exhibits neuroprotective effects in preclinical Parkinson disease (PD) models.MethodsThis Phase 2A double-blind placebo-controlled study in moderate/advanced PD randomized participants 1:1:1 t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74992814e008d8ca9ded7e144e645eb9
Autor:
Jaime Adams, Samuel Frank, Deborah Baker, Saurav Brahmachari, Elizabeth A. Klingner, Jason Aldred, Jennifer Mule, Meredith Spindler, Cornelia Kamp, Phounsavath Muneath, Claudia Rocha, Liana Baker, Gian Pal, Doozie Russell, Yvette Pitchford, Tina Ward, Olga Kishchenko, Kellie Keith, Angela S Stovall, Courtney Blair, John Slevin Slevin, Vanessa K. Hinson, Grace Bwala, Brian K. Fiske, Liana S. Rosenthal, Joohi Shahed, Andrew P. Duker, Patrick Bolger, Gary Rafaloff, David Weiner, Adolfo Ramirez-Zamora, Zoltan Mari, Renee Wagner Wagner, Helen Matthews, Karen Blindauer, Derek B. Ridgeway, Alexandria Oliver, Carlinda Field, Stephanie Burrows, Binit B. Shah, Lauren Seeberger, Charles S. Venuto, Katie Sullivan, Laura Ramirez, Erika F. Augustine, Matthew Swan, Lilliana Dumitrescu, Natividad Stover, Shonna Jenkins, Sharon Evans, Lin Zhang, Anwar Ahmed, Tanya Simuni, Michael A. Schwarzschild, Christopher S. Coffey, Mark S. LeDoux, David-Erick Lafontant, Laura Trusso, Farah Ismail, John L. Goudreau, Eric Molho, Sue Henderson, Cindy Casaceli, Christine Hunter, Holly Reynolds, Albert Y. Hung, Robert A. Hauser, Burton L. Scott, Lynn Wheeler, Kalpana Merchant, Chelsea Caspell-Garcia, Claire E. Wegel, Richard K. Wyse, Patrik Brundin, Christina Gruenwald, Alicia Brocht, Candace Cromer, Lisa Gauger, Melissa Bixby, Emily Carman, Kathryn A. Chung, Nichole McMullen, David Simon, Ken Eaton, Oren A. Levy, Amber Servi, Abigail Simpson, Holly A. Shill, Kelvin L. Chou, Melissa Kostrzebski, Ted M. Dawson
Publikováno v:
JAMA Neurology. 78:312
Importance There is a critical need for careful and independent validation of reported symptomatic efficacy and dopaminergic biomarker changes induced by nilotinib in Parkinson disease (PD). Objectives To assess safety and tolerability of nilotinib i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8da5bef13be163263b4f128491abd097
https://doi.org/10.1001/jamaneurol.2020.4725
https://doi.org/10.1001/jamaneurol.2020.4725
Autor:
Stephanie Lowenhaupt, Debra Babcock, Bernard Ravina, Liana Baker, Pei Shieen Wong, Sheng Luo, Pauline LeBlanc, Barbara C. Tilley, Julie H. Carter, Robert A. Hauser, Nabila Dahodwala, Marina E. Emborg, David Simon, Rohit Dhall, John Y. Fang, Andrew Feigin, Richard M. Zweig, Jacci Bainbridge, John C. Morgan, Binit B. Shah, Karen Williams, Kathleen M. Shannon, Buff Farrow, Karl Kieburtz, Daniel D. Truong, Renee Wagner, Cindy Zadikoff, Tanya Simuni, Sofya Glazman, Carlos Singer, Mark F. Lew, Kelvin L. Chou, Rajesh Pahwa, Saloni Sharma, Cornelia Kamp, James T. Boyd, Jordan J. Elm, Maureen A. Leehey, John L. Goudreau, Burton L. Scott, Adriana Pérez, Franca Cambi, Ivan Bodis-Wollner, Anne-Marie Wills, Stephen L. Lee, Jay S. Schneider, G. Webster Ross, Richard B. Dewey
Publikováno v:
The Lancet Neurology. 14:795-803
Summary Background A systematic assessment of potential disease-modifying compounds for Parkinson's disease concluded that pioglitazone could hold promise for the treatment of patients with this disease. We assessed the effect of pioglitazone on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a49a30cdc60e8ef42e5f4cbc6242c5cb
https://doi.org/10.1016/s1474-4422(15)00144-1
https://doi.org/10.1016/s1474-4422(15)00144-1
Autor:
Deborah J. Ossip, Karen M. Mustian, Joseph J. Guido, Liana Baker, Scott McIntosh, Christopher L. Seplaki, Lara Anne Trevino
Publikováno v:
Addictive Behaviors. 39:885-888
Smoking prevalence for those ages 45–65 is higher than the national average and the number of mid-life and older smokers is expected to increase as baby boomers age. Cessation, even after age 65, confers health benefits. Both physiologic and psycho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd682591f1e4b2f15041299da2d0d89
https://doi.org/10.1016/j.addbeh.2014.01.014
https://doi.org/10.1016/j.addbeh.2014.01.014
Autor:
Tanya Simuni, Bernard Ravina, Cornelia Kamp, John C. Morgan, Joanne Clark-Matott, Saloni Sharma, Liana Baker, Jordan J. Elm, G. Webster Ross, Marina E. Emborg, Susan R. Dunlop, David Simon, Allison K. Graebner
Publikováno v:
Journal of Parkinson's disease. 5(4)
Pioglitazone, an oral hypoglycemic agent, recently failed to show promise as a disease-modifying agent in a 44-week phase 2 placebo-controlled study in 210 Parkinson's disease (PD) subjects. We analyzed peripheral biomarkers, including leukocyte PGC-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8ff5f0359261571a0ff6c82d74780c0
https://pubmed.ncbi.nlm.nih.gov/26444095
https://pubmed.ncbi.nlm.nih.gov/26444095